The rise in influencer and endorser advertising, particularly for consumer health and drug products, is leading to an increase in regulatory scrutiny of social media. This webinar will discuss the recent changes in FDA, FTC and NAD guidance and the implications for life sciences companies.
The rise in influencer and endorser advertising, particularly for consumer health and drug products, is leading to an increase in regulatory scrutiny of social media. This webinar will discuss the recent changes in FDA, FTC and NAD guidance and the implications for life sciences companies.
Topics will include:
- The Sunshine Act and Fair Market Value considerations when using Healthcare Professional (HCP) influencers;
- Key strategies for developing influencer agreements;
- How to effectively monitor influencers and agencies once the contract is signed, and more.
Speakers:
Theresa House, Partner, Intellectual Property & Technology
Raqiyyah Pippins, Partner, Consumer Products and Life Sciences and Healthcare Regulatory
Abraham Gitterman, Senior Associate, Life Sciences and Healthcare Regulatory
Date
December 13, 2022
Time
12:00 PM - 1:00 PM ET
CLE Credit
Pending
